Who invested in TP Therapeutics?
TP Therapeutics's investors include OrbiMed, Lilly Asia Ventures, SR One, Foresite Capital and Cormorant Capital, and 4 more on record.
United States · Funded startup
3 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$126Mraised across 3 rounds since 2014, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $80M sold, first sale Oct 2018
Reported by FinSMEsSEC filing: $45M sold, first sale May 2017
No investor was named in the report.
From a historical funding recordSEC filing: $1.4M sold, first sale Dec 2013
From the SEC filings it signed: 2 on the team.
On the board, as filediBrett J. ZbarCarl Maria GordonHongbo Maria LuKenneth FongLewis J. ShusterRobert J. AdelmanSheila K. GujrathiSimeon Maria GeorgeYishan Li
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
TP Therapeutics's investors include OrbiMed, Lilly Asia Ventures, SR One, Foresite Capital and Cormorant Capital, and 4 more on record.
TP Therapeutics has raised $126M across 3 rounds since 2014.
TP Therapeutics's most recent round was an Undisclosed round of $80M in Oct 2018.
Its most recent round, $80M in Oct 2018, is also its largest on record.
TP Therapeutics's first round on record, in May 2017, was backed by OrbiMed, Lilly Asia Ventures and SV Tech Ventures and 1 others.
TP Therapeutics's latest named round is an Undisclosed round, in Oct 2018.
TP Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.